Arnatar Therapeutics

arnatar.com

We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, rare liver, and rare kidney diseases. Our proprietary Darger™ platform enables both gene upregulation and downregulation using novel Antisense Oligonucleotide (ASO) and Small Interfering RNA (siRNA) approaches.